+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oral Solid Dosage CDMO Market Size, Share & Trends Analysis Report by Product (Tablets, Capsules, Powder, Granules), Mechanism, Drug Potency, Service, End Use, and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 250 Pages
  • December 2025
  • Region: Global
  • Grand View Research
  • ID: 6098063
REQUEST CUSTOMIZATION
Description Jump to:
The global oral solid dosage CDMO market size was estimated at USD 43.65 billion in 2024 and is projected to reach USD 77.06 billion by 2033, growing at a CAGR of 6.56% from 2025 to 2033. The market growth is driven by a rising demand for cost-efficient drug development, increasing outsourcing by pharmaceutical and biotech companies, and growing consumption of tablets and capsules for chronic and lifestyle diseases, owing to ease of administration and precise dosage, which enhances the requirement for oral solid dosage CDMO services.

Other factors contributing to market growth include the expansion of generic drugs, patent expiries, and the need for flexible manufacturing capacity. Most companies rely on CDMOs to access advanced formulation capabilities, scale up production efficiently, and meet stringent regulatory and quality requirements. In addition, technological advancement and increased reliance on CDMOs for end-to-end OSD development and manufacturing services are expected to drive the market.

The growing prevalence of chronic and infectious diseases is a significant factor driving the demand for novel therapies. In addition, the growing geriatric population is contributing to the rising incidence of chronic diseases, further supporting the demand for novel therapies. Another factor contributing to market growth is adverse drug reactions to existing drugs, which have increased the demand for novel treatment options.

Moreover, several solid dosage forms are currently available on the market due to ongoing advancements in drug delivery technology, rising investments by contract development and manufacturing organizations (CDMOs) to expand OSD development, and increasing demand for novel therapies, all of which further contribute to market growth.

Global Oral Solid Dosage Market Report Segmentation

This report forecasts revenue growth at a country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. The report has segmented the global oral solid dosage CDMO market report based on product, mechanism, drug potency, service, end use, and region:

Product Outlook (Revenue, USD Million, 2021-2033)

  • Tablets
  • Capsules
  • Powders
  • Granules
  • Others

Mechanism Outlook (Revenue, USD Million, 2021-2033)

  • Immediate Release
  • Delayed Release
  • Controlled Release

Drug Potency Outlook (Revenue, USD Million, 2021-2033)

  • High Potent Drugs
  • Moderate Potent Drugs
  • Low Potent Drugs

Service Outlook (Revenue, USD Million, 2021-2033)

  • Contract Development
  • Contract Manufacturing
  • Packaging and Labelling
  • Regulatory Affairs
  • Logistics & Storage
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Large Size Companies
  • Medium & Small Size Companies
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Mechanism
1.2.3. Drug Potency
1.2.4. Service
1.2.5. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Top-Down Analysis
1.7.3. Botton-Up Approach
1.7.4. Multivariate Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Oral Solid Dosage CDMO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Tariff Impact Analysis
3.6. Value Chain Analysis
3.6.1. Supply Trends
3.6.2. Demand Trends
3.7. Market Analysis Tools
3.7.1. Porter’s Five Force Analysis
3.7.2. PESTEL by SWOT Analysis
Chapter 4. Oral Solid Dosage CDMO Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2024 & 2033
4.2. Product Segment Dashboard
4.3. Oral Solid Dosage CDMO Market: Product Movement Analysis
4.4. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.5. Tablets
4.5.1. Tablets Market Estimates & Forecasts, 2021 to 2033 (USD Million)
4.5.2. Compressed Tablets
4.5.2.1. Compressed Tablets Market Estimates & Forecasts, 2021-2033 (USD Million)
4.5.3. Orally Disintegrating Tablets (ODT)
4.5.3.1. Orally Disintegrating Tablets (ODT) Market Estimates & Forecasts, 2021-2033 (USD Million)
4.5.4. Chewable Tablets
4.5.4.1. Chewable Tablets Market Estimates & Forecasts, 2021-2033 (USD Million)
4.5.5. Bi-layer or Tri-layer Tablets
4.5.5.1. Bi-layer or Tri-layer Tablets Market Estimates & Forecasts, 2021-2033 (USD Million)
4.5.6. Sublingual or Buccal Tablets
4.5.6.1. Sublingual or Buccal Tablets Market Estimates & Forecasts, 2021-2033 (USD Million)
4.5.7. Others
4.5.7.1. Others Market Estimates & Forecasts, 2021-2033 (USD Million)
4.6. Capsules
4.6.1. Capsules Market Estimates & Forecasts, 2021 to 2033 (USD Million)
4.6.2. Hard Gelatin Capsules
4.6.2.1. Hard Gelatin Capsules Market Estimates & Forecasts, 2021-2033 (USD Million)
4.6.3. Soft Gelatin Capsules
4.6.3.1. Soft Gelatin Capsules Market Estimates & Forecasts, 2021-2033 (USD Million)
4.7. Powder
4.7.1. Powder Market Estimates & Forecasts, 2021-2033 (USD Million)
4.8. Granules
4.8.1. Granules Market Estimates & Forecasts, 2021-2033 (USD Million)
4.9. Others
4.9.1. Others Market Estimates & Forecasts, 2021-2033 (USD Million)
Chapter 5. Oral Solid Dosage CDMO Market: Mechanism Estimates & Trend Analysis
5.1. Mechanism Market Share, 2024 & 2033
5.2. Mechanism Segment Dashboard
5.3. Global Oral Solid Dosage CDMO Market: Mechanism Movement Analysis
5.4. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Mechanism, 2021 to 2033 (USD Million)
5.5. Immediate Release
5.5.1. Immediate Release Market Estimates & Forecasts, 2021-2033 (USD Million)
5.6. Delayed Release
5.6.1. Delayed Release Market Estimates & Forecasts, 2021-2033 (USD Million)
5.7. Controlled Release
5.7.1. Controlled Release Market Estimates & Forecasts, 2021-2033 (USD Million)
Chapter 6. Oral Solid Dosage CDMO Market: Drug Potency Estimates & Trend Analysis
6.1. Drug Potency Market Share, 2024 & 2033
6.2. Drug Potency Segment Dashboard
6.3. Oral Solid Dosage CDMO Market: Drug Potency Movement Analysis
6.4. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Drug Potency, 2021 to 2033 (USD Million)
6.5. High Potent Drugs
6.5.1. High Potent Drugs Market Estimates & Forecasts, 2021-2033 (USD Million)
6.6. Moderate Potent Drugs
6.6.1. Moderate Potent Drugs Market Estimates & Forecasts, 2021-2033 (USD Million)
6.7. Low Potent Drugs
6.7.1. Low Potent Drugs Market Estimates & Forecasts, 2021-2033 (USD Million)
Chapter 7. Oral Solid Dosage CDMO Market: Service Estimates & Trend Analysis
7.1. Service Market Share, 2024 & 2033
7.2. Service Segment Dashboard
7.3. Oral Solid Dosage CDMO Market: Service Movement Analysis
7.4. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Service, 2021 to 2033 (USD Million)
7.5. Contract Development
7.5.1. Contract Development Market Estimates & Forecasts, 2021-2033 (USD Million)
7.6. Contract Manufacturing
7.6.1. Contract Manufacturing Market Estimates & Forecasts, 2021-2033 (USD Million)
7.7. Packaging and Labelling
7.7.1. Packaging and Labelling Market Estimates & Forecasts, 2021-2033 (USD Million)
7.8. Regulatory Affairs
7.8.1. Regulatory Affairs Market Estimates & Forecasts, 2021-2033 (USD Million)
7.9. Logistics & Storage
7.9.1. Logistics & Storage Market Estimates & Forecasts, 2021-2033 (USD Million)
7.10. Others
7.10.1. Others Market Estimates & Forecasts, 2021-2033 (USD Million)
Chapter 8. Oral Solid Dosage CDMO Market: End Use Estimates & Trend Analysis
8.1. End Use Market Share, 2024 & 2033
8.2. End Use Segment Dashboard
8.3. Oral Solid Dosage CDMO Market: End Use Movement Analysis
8.4. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
8.5. Large Size Companies
8.5.1. Large Size Companies Market Estimates & Forecasts, 2021-2033 (USD Million)
8.6. Medium & Small Size Companies
8.6.1. Medium & Small Size Companies Market Estimates & Forecasts, 2021-2033 (USD Million)
8.7. Others
8.7.1. Others Market Estimates & Forecasts, 2021-2033 (USD Million)
Chapter 9. Oral Solid Dosage CDMO Market: Regional Estimates & Trend Analysis
9.1. Regional Market Dashboard
9.2. Oral Solid Dosage CDMO Market: Regional Movement Analysis
9.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
9.4. North America
9.4.1. North America Oral Solid Dosage CDMO Market Estimates & Forecasts, by Country, 2021-2033 (USD Million)
9.4.2. U.S.
9.4.2.1. Key Country Dynamics
9.4.2.2. Regulatory Framework
9.4.2.3. U.S. Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.4.3. Canada
9.4.3.1. Key Country Dynamics
9.4.3.2. Regulatory Framework
9.4.3.3. U.S. Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.4.4. Mexico
9.4.4.1. Key Country Dynamics
9.4.4.2. Regulatory Framework
9.4.4.3. Mexico Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.5. Europe
9.5.1. Europe Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.5.2. UK
9.5.2.1. Key Country Dynamics
9.5.2.2. Regulatory Framework
9.5.2.3. UK Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.5.3. Germany
9.5.3.1. Key Country Dynamics
9.5.3.2. Regulatory Framework
9.5.3.3. Germany Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.5.4. France
9.5.4.1. Key Country Dynamics
9.5.4.2. Regulatory Framework
9.5.4.3. France Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.5.5. Italy
9.5.5.1. Key Country Dynamics
9.5.5.2. Regulatory Framework
9.5.5.3. Italy Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.5.6. Spain
9.5.6.1. Key Country Dynamics
9.5.6.2. Regulatory Framework
9.5.6.3. Spain Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.5.7. Denmark
9.5.7.1. Key Country Dynamics
9.5.7.2. Regulatory Framework
9.5.7.3. Denmark Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.5.8. Sweden
9.5.8.1. Key Country Dynamics
9.5.8.2. Regulatory Framework
9.5.8.3. Sweden Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.5.9. Norway
9.5.9.1. Key Country Dynamics
9.5.9.2. Regulatory Framework
9.5.9.3. Norway Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.6. Asia-Pacific
9.6.1. Asia-Pacific Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.6.2. Japan
9.6.2.1. Key Country Dynamics
9.6.2.2. Regulatory Framework
9.6.2.3. Japan Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.6.3. China
9.6.3.1. Key Country Dynamics
9.6.3.2. Regulatory Framework
9.6.3.3. China Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.6.4. India
9.6.4.1. Key Country Dynamics
9.6.4.2. Regulatory Framework
9.6.4.3. India Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.6.5. Australia
9.6.5.1. Key Country Dynamics
9.6.5.2. Regulatory Framework
9.6.5.3. Australia Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.6.6. South Korea
9.6.6.1. Key Country Dynamics
9.6.6.2. Regulatory Framework
9.6.6.3. South Korea Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.6.7. Thailand
9.6.7.1. Key Country Dynamics
9.6.7.2. Regulatory Framework
9.6.7.3. Thailand Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.7. Latin America
9.7.1. Latin America Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.7.2. Brazil
9.7.2.1. Key Country Dynamics
9.7.2.2. Regulatory Framework
9.7.2.3. Japan Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.7.3. Argentina
9.7.3.1. Key Country Dynamics
9.7.3.2. Regulatory Framework
9.7.3.3. China Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.8. Middle East and Africa
9.8.1. Middle East and Africa Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.8.2. South Africa
9.8.2.1. Key Country Dynamics
9.8.2.2. Regulatory Framework
9.8.2.3. South Africa Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.8.3. Saudi Arabia
9.8.3.1. Key Country Dynamics
9.8.3.2. Regulatory Framework
9.8.3.3. Saudi Arabia Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.8.4. UAE
9.8.4.1. Key Country Dynamics
9.8.4.2. Regulatory Framework
9.8.4.3. UAE Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.8.5. Kuwait
9.8.5.1. Key Country Dynamics
9.8.5.2. Regulatory Framework
9.8.5.3. Kuwait Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.8.6. Qatar
9.8.6.1. Key Country Dynamics
9.8.6.2. Regulatory Framework
9.8.6.3. Qatar Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
9.8.7. Oman
9.8.7.1. Key Country Dynamics
9.8.7.2. Regulatory Framework
9.8.7.3. Oman Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021-2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Participant Overview
10.2. Company Market Position Analysis
10.3. Company Categorization
10.4. Strategy Mapping
10.5. Company Profiles/Listing
10.5.1. Lonza
10.5.1.1. Company Overview
10.5.1.2. Financial Performance
10.5.1.3. Product Benchmarking
10.5.1.4. Strategic Initiatives
10.5.2. Thermo Fisher Scientific Inc.
10.5.2.1. Company Overview
10.5.2.2. Financial Performance
10.5.2.3. Product Benchmarking
10.5.2.4. Strategic Initiatives
10.5.3. Cambrex Corporation
10.5.3.1. Company Overview
10.5.3.2. Financial Performance
10.5.3.3. Product Benchmarking
10.5.3.4. Strategic Initiatives
10.5.4. Catalent, Inc.
10.5.4.1. Company Overview
10.5.4.2. Financial Performance
10.5.4.3. Product Benchmarking
10.5.4.4. Strategic Initiatives
10.5.5. Siegrfried Holding AG
10.5.5.1. Company Overview
10.5.5.2. Financial Performance
10.5.5.3. Product Benchmarking
10.5.5.4. Strategic Initiatives
10.5.6. Recipharm AB
10.5.6.1. Company Overview
10.5.6.2. Financial Performance
10.5.6.3. Product Benchmarking
10.5.6.4. Strategic Initiatives
10.5.7. CordenPharma International
10.5.7.1. Company Overview
10.5.7.2. Financial Performance
10.5.7.3. Product Benchmarking
10.5.7.4. Strategic Initiatives
10.5.8. Boehringer Ingelheim
10.5.8.1. Company Overview
10.5.8.2. Financial Performance
10.5.8.3. Product Benchmarking
10.5.8.4. Strategic Initiatives
10.5.9. Piramal Pharma Solutions
10.5.9.1. Company Overview
10.5.9.2. Financial Performance
10.5.9.3. Product Benchmarking
10.5.9.4. Strategic Initiatives
10.5.10. Aenova Group
10.5.10.1. Company Overview
10.5.10.2. Financial Performance
10.5.10.3. Product Benchmarking
10.5.10.4. Strategic Initiatives
10.5.11. Almac Group
10.5.11.1. Company Overview
10.5.11.2. Financial Performance
10.5.11.3. Product Benchmarking
10.5.11.4. Strategic Initiatives
10.5.12. Jubilant Pharmova Limited
10.5.12.1. Company Overview
10.5.12.2. Financial Performance
10.5.12.3. Product Benchmarking
10.5.12.4. Strategic Initiatives
10.5.13. Delpharm
10.5.13.1. Company Overview
10.5.13.2. Financial Performance
10.5.13.3. Product Benchmarking
10.5.13.4. Strategic Initiatives
10.5.14. AbbVie Contract Manufacturing
10.5.14.1. Company Overview
10.5.14.2. Financial Performance
10.5.14.3. Product Benchmarking
10.5.14.4. Strategic Initiatives
10.5.15. Next Pharma AB
10.5.15.1. Company Overview
10.5.15.2. Financial Performance
10.5.15.3. Product Benchmarking
10.5.15.4. Strategic Initiatives
10.5.16. Rubicon Research Pvt. Ltd.
10.5.16.1. Company Overview
10.5.16.2. Financial Performance
10.5.16.3. Product Benchmarking
10.5.16.4. Strategic Initiatives
10.5.17. Quotient Sciences
10.5.17.1. Company Overview
10.5.17.2. Financial Performance
10.5.17.3. Product Benchmarking
10.5.17.4. Strategic Initiatives
10.5.18. SPI Pharma
10.5.18.1. Company Overview
10.5.18.2. Financial Performance
10.5.18.3. Product Benchmarking
10.5.18.4. Strategic Initiatives
10.5.19. DPT Laboratories Ltd.
10.5.19.1. Company Overview
10.5.19.2. Financial Performance
10.5.19.3. Product Benchmarking
10.5.19.4. Strategic Initiatives
10.5.20. Alcami Corporation
10.5.20.1. Company Overview
10.5.20.2. Financial Performance
10.5.20.3. Product Benchmarking
10.5.20.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List Of Abbreviations
Table 3 Global Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 4 Global Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 5 Global Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 6 Global Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 7 Global Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 8 Global Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 9 Global Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 10 Global Oral Solid Dosage CDMO Market, by Region, 2021-2033 (USD Million)
Table 11 North America Oral Solid Dosage CDMO Market, by Country, 2021-2033 (USD Million)
Table 12 North America Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 13 North America Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 14 North America Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 15 North America Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 16 North America Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 17 North America Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 18 North America Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 19 U.S. Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 20 U.S. Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 21 U.S. Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 22 U.S. Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 23 U.S. Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 24 U.S. Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 25 U.S. Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 26 Canada Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 27 Canada Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 28 Canada Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 29 Canada Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 30 Canada Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 31 Canada Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 32 Canada Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 33 Mexico Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 34 Mexico Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 35 Mexico Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 36 Mexico Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 37 Mexico Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 38 Mexico Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 39 Mexico Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 40 Europe Oral Solid Dosage CDMO Market, by Country, 2021-2033 (USD Million)
Table 41 Europe Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 42 Europe Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 43 Europe Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 44 Europe Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 45 Europe Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 46 Europe Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 47 Europe Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 48 UK Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 49 UK Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 50 UK Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 51 UK Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 52 UK Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 53 UK Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 54 UK Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 55 Germany Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 56 Germany Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 57 Germany Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 58 Germany Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 59 Germany Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 60 Germany Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 61 Germany Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 62 France Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 63 France Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 64 France Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 65 France Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 66 France Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 67 France Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 68 France Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 69 Italy Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 70 Italy Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 71 Italy Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 72 Italy Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 73 Italy Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 74 Italy Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 75 Italy Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 76 Spain Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 77 Spain Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 78 Spain Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 79 Spain Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 80 Spain Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 81 Spain Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 82 Spain Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 83 Sweden Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 84 Sweden Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 85 Sweden Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 86 Sweden Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 87 Sweden Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 88 Sweden Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 89 Sweden Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 90 Norway Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 91 Norway Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 92 Norway Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 93 Norway Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 94 Norway Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 95 Norway Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 96 Norway Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 97 Denmark Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 98 Denmark Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 99 Denmark Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 100 Denmark Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 101 Denmark Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 102 Denmark Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 103 Denmark Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 104 Asia-Pacific Oral Solid Dosage CDMO Market, by Country, 2021-2033 (USD Million)
Table 105 Asia-Pacific Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 106 Asia-Pacific Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 107 Asia-Pacific Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 108 Asia-Pacific Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 109 Asia-Pacific Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 110 Asia-Pacific Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 111 Asia-Pacific Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 112 China Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 113 China Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 114 China Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 115 China Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 116 China Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 117 China Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 118 China Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 119 Japan Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 120 Japan Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 121 Japan Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 122 Japan Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 123 Japan Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 124 Japan Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 125 Japan Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 126 India Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 127 India Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 128 India Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 129 India Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 130 India Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 131 India Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 132 India Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 133 Australia Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 134 Australia Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 135 Australia Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 136 Australia Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 137 Australia Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 138 Australia Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 139 Australia Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 140 Thailand Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 141 Thailand Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 142 Thailand Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 143 Thailand Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 144 Thailand Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 145 Thailand Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 146 Thailand Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 147 South Korea Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 148 South Korea Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 149 South Korea Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 150 South Korea Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 151 South Korea Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 152 South Korea Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 153 South Korea Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 154 Latin America Oral Solid Dosage CDMO Market, by Country, 2021-2033 (USD Million)
Table 155 Latin America Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 156 Latin America Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 157 Latin America Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 158 Latin America Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 159 Latin America Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 160 Latin America Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 161 Latin America Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 162 Brazil Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 163 Brazil Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 164 Brazil Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 165 Brazil Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 166 Brazil Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 167 Brazil Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 168 Brazil Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 169 Argentina Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 170 Argentina Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 171 Argentina Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 172 Argentina Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 173 Argentina Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 174 Argentina Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 175 Argentina Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 176 Middle East and Africa Oral Solid Dosage CDMO Market, by Country, 2021-2033 (USD Million)
Table 177 Middle East and Africa Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 178 Middle East and Africa Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 179 Middle East and Africa Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 180 Middle East and Africa Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 181 Middle East and Africa Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 182 Middle East and Africa Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 183 Middle East and Africa Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 184 Saudi Arabia Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 185 Saudi Arabia Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 186 Saudi Arabia Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 187 Saudi Arabia Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 188 Saudi Arabia Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 189 Saudi Arabia Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 190 Saudi Arabia Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 191 South Africa Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 192 South Africa Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 193 South Africa Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 194 South Africa Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 195 South Africa Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 196 South Africa Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 197 South Africa Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 198 UAE Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 199 UAE Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 200 UAE Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 201 UAE Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 202 UAE Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 203 UAE Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 204 UAE Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 205 Kuwait Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 206 Kuwait Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 207 Kuwait Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 208 Kuwait Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 209 Kuwait Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 210 Kuwait Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 211 Kuwait Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 212 Oman Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 213 Oman Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 214 Oman Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 215 Oman Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 216 Oman Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 217 Oman Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 218 Oman Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
Table 219 Qatar Oral Solid Dosage CDMO Market, by Product, 2021-2033 (USD Million)
Table 220 Qatar Oral Solid Dosage CDMO Market, by Tablets, 2021-2033 (USD Million)
Table 221 Qatar Oral Solid Dosage CDMO Market, by Capsules, 2021-2033 (USD Million)
Table 222 Qatar Oral Solid Dosage CDMO Market, by Mechanism, 2021-2033 (USD Million)
Table 223 Qatar Oral Solid Dosage CDMO Market, by Drug Potency, 2021-2033 (USD Million)
Table 224 Qatar Oral Solid Dosage CDMO Market, by Service, 2021-2033 (USD Million)
Table 225 Qatar Oral Solid Dosage CDMO Market, by End Use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value-Chain-Based Sizing & Forecasting
Figure 6 Market Formulation & Validation
Figure 7 Market Snapshot
Figure 8 Therapeutic Approach (USD Million)
Figure 9 Competitive Landscape
Figure 10 Oral Solid Dosage CDMO Market Dynamics
Figure 11 Oral Solid Dosage CDMO Market: Porter’s Five Forces Analysis
Figure 12 Oral Solid Dosage CDMO Market: PESTLE analysis
Figure 13 Global Oral Solid Dosage CDMO Market: Product Movement Analysis
Figure 14 Global Oral Solid Dosage CDMO Market: Product Outlook and Key Takeaways
Figure 15 Tablets Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 16 Compressed Tablets Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 17 Orally Disintegrating Tablets (ODT) Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 18 Chewable Tablets Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 19 Bi-layer or Tri-layer Tablets Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 20 Sublingual or Buccal Tablets Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 21 Others Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 22 Capsules Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 23 Hard Gelatin Capsules Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 24 Soft Gelatin Capsules Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 25 Powder Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 26 Granules Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 27 Others Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 28 Global Oral Solid Dosage CDMO Market: Mechanism Movement Analysis
Figure 29 Global Oral Solid Dosage CDMO Market: Mechanism Outlook and Key Takeaways
Figure 30 Immediate Release Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 31 Delayed Release Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 32 Controlled Release Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 33 Global Oral Solid Dosage CDMO Market: Drug Potency Movement Analysis
Figure 34 Global Oral Solid Dosage CDMO Market: Drug Potency Outlook and Key Takeaways
Figure 35 High Potent Drugs Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 36 Moderate Potent Drugs Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 37 Low Potent Drugs Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 38 Global Oral Solid Dosage CDMO Market: Service Movement Analysis
Figure 39 Global Oral Solid Dosage CDMO Market: Service Outlook and Key Takeaways
Figure 40 Contract Development Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 41 Contract Manufacturing Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 42 Packaging and Labelling Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 43 Regulatory Market Affairs Estimates and Forecast, 2021-2033 (USD Million)
Figure 44 Logistics & Storage Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 45 Others Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 46 Global Oral Solid Dosage CDMO Market: End Use Movement Analysis
Figure 47 Global Oral Solid Dosage CDMO Market: End Use Outlook and Key Takeaways
Figure 48 Large Size Companies Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 49 Medium & Small Size Companies Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 50 Others Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 51 Regional Marketplace: Key Takeaways
Figure 52 North America Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 53 Key Country Dynamics
Figure 54 U.S. Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 55 Key Country Dynamics
Figure 56 Canada Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 57 Key Country Dynamics
Figure 58 Mexico Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 59 Europe Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 60 Key Country Dynamics
Figure 61 UK Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 62 Key Country Dynamics
Figure 63 Germany Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 64 Key Country Dynamics
Figure 65 France Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 66 Key Country Dynamics
Figure 67 Italy Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 68 Key Country Dynamics
Figure 69 Spain Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 70 Key Country Dynamics
Figure 71 Denmark Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 72 Key Country Dynamics
Figure 73 Sweden Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 74 Key Country Dynamics
Figure 75 Norway Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 76 Asia-Pacific Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 77 Key Country Dynamics
Figure 78 Japan Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 79 Key Country Dynamics
Figure 80 China Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 81 Key Country Dynamics
Figure 82 India Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 83 Key Country Dynamics
Figure 84 Thailand Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 85 Key Country Dynamics
Figure 86 South Korea Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 87 Key Country Dynamics
Figure 88 Australia Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 89 Latin America Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 90 Key Country Dynamics
Figure 91 Brazil Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 92 Key Country Dynamics
Figure 93 Argentina Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 94 MEA Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 95 Key Country Dynamics
Figure 96 South Africa Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 97 Key Country Dynamics
Figure 98 Saudi Arabia Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 99 Key Country Dynamics
Figure 100 UAE Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 101 Key Country Dynamics
Figure 102 Kuwait Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 103 Key Country Dynamics
Figure 104 Oman Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 105 Key Country Dynamics
Figure 106 Qatar Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021-2033 (USD Million
Figure 107 Participant Categorization
Figure 108 Company Market Position Analysis
Figure 109 Strategic Framework

Companies Mentioned

The companies profiled in this Oral Solid Dosage CDMO market report include:
  • Lonza
  • Thermo Fisher Scientific Inc.
  • Cambrex Corporation
  • Catalent Inc.
  • Siegrfried Holding AG
  • Recipharm AB
  • CordenPharma International
  • Boehringer Ingelheim
  • Piramal Pharma Solutions
  • Aenova Group
  • Almac Group
  • Jubilant Pharmova Limited
  • Delpharm
  • AbbVie Contract Manufacturing
  • Next Pharma AB
  • Rubicon Research Pvt. Ltd.
  • Quotient Sciences
  • SPI Pharma
  • DPT Laboratories Ltd.
  • Alcami Corporation

Table Information

Report AttributeDetails
No. of Pages250
PublishedDecember 2025
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 46.37 Billion
Forecasted Market Value ( USD ) by 2033 $ 77.06 Billion
Compound Annual Growth Rate6.5%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) for Formulations Market Report 2025 - Product Image

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) for Formulations Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Semi-Solid Dosage CDMO Market Size, Share & Trends Analysis Report By Route of Administration (Topical, Transdermal), By Product, By Service, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Semi-Solid Dosage CDMO Market Size, Share & Trends Analysis Report By Route of Administration (Topical, Transdermal), By Product, By Service, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 145 Pages
  • Global
From
Semi-Solid Dosage CDMO Market - Global Strategic Business Report - Product Image

Semi-Solid Dosage CDMO Market - Global Strategic Business Report

  • Report
  • 464 Pages
  • Global
From
Small Molecules CDMO Services Market - Global Forecast 2026-2032 - Product Image

Small Molecules CDMO Services Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Pharmaceutical Contract Development and Manufacturing Organization (CDMO) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 317 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.